Progress in the Prevention of Complications of Interventional Therapy in Patients with Lung Cancer Hemoptysis

Abstract

Lung cancer is the malignant tumor with the highest incidence and mortality in our country and even in the world. The radical rate of conventional therapy, such as simple radiotherapy, chemotherapy, operation, traditional Chinese medicine treatment is low and the effect is not ideal. Bronchial lung cancer is one of the most common causes of massive hemoptysis. Vascular interventional therapy has become the first choice in clinical treatment of acute massive hemoptysis. Interventional therapy for lung cancer patients, as a safe, efficient, minimally invasive and economical treatment, has been widely used at home and abroad. However, due to inadequate patient assessment, equipment may not be advanced enough, and treatment techniques need to be developed, more or less postoperative complications associated with interventional therapy may occur. This article reviews the research status of interventional therapy and complication prevention in patients with lung cancer hemoptysis as follows.